Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib may help regrow hair in alopecia areata patients.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

PT-20 did not significantly improve gray hair repigmentation.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

i-PRF and A-PRF are promising treatments for hair regrowth in androgenetic alopecia.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Pulsed electric field treatment may help shrink untreated liver tumors.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Promising cancer treatments were found, but the manufacturer closed.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

PDGF isoforms can promote and sustain hair growth.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Atopy and altered T cell functions contribute to Alopecia Areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.